Biosimilars: British Columbia extends transition program

By Aurélia Morvan | October 03 2019 11:14AM

Photo: Freepik

Rising drug costs are plaguing public and private health insurance plans alike. In response to this trend, British Columbia has extended its program which transitions patients to biosimilar drugs.

This article is reserved to PRO Level subscribers

Read the whole article….


$9.95 / month

Related to the same topic …